ORIGINAL PAPERS |
|
E.A. Popov
Life on hemodialysis: patients’ look into the future
|
6-9 |
|
O.N. Sharapov, B.T. Daminov, S.V. Yarygina, V.A. Dyagilev
Comparative evaluation of the structure of cardiovascular diseases of the rural and urban population of the republic of uzbekistan, suffering from stage 5 ckd on programmed hemodialysis
|
10-14 |
|
A.V. Yakunin, M.R. Sheykhov, O.N. Kotenko, L.M. Kondrashova, N.V. Vasina
Social support for ckd patients on dialysis in an inpatient social institution
|
15-21 |
|
I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, I.O. Kudaibergenova, Zh.A. Murkamilova, F.A. Yusupov
Renal function and cytokine profile changes with COVID-19
|
22-30 |
|
E.V. Shutov, G.V. Kotlyarova, K.M. Lysenko, G.V. Ryabinskaya, S.V. Lashutin
The efficacy and safety of the sucroferric oxyhydroxide (Velphoro®) in hemodialysis patients: results of a prospective randomized controlled trial
|
31-36 |
LITERATURE REVIEWS |
|
I.Т. Murkamilov, I.S. Sabirov, V.V. Fomin, Zh.A. Murkamilova, F.A. Yusupov, N.A. Redzhapova, Z.R. Rayimzhanov
Ezetimibe in chronic kidney disease: an effect on the risk of developing cardiovascular and cerebral complications
|
37-44 |
School of Moscow Nephrologist |
|
Differential diagnosis of thrombotic microangiopathies. Program
|
45 |
|
T.V. Kirsanova
Difficulties in differential diagnosis of different variants of TMA: from urgent to "silent" forms with life-threatening consequences
|
46-52 |
|
S.A. Krivushkin
Modern approaches to the diagnosis and treatment of atypical hemolytic uremic syndrome: analysis of clinical cases
|
53-54 |
|
N.V. Vasina
Routing of patients with newly diagnosed atypical hemolytic uremic syndrome
|
55-56 |
Obituary |
|
Aleksey Yur'yevich Nikolayev
|
57 |
Русский
